Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
1 needle + 1 syringe + 1 time = 0 infections
Filetype[PDF-495.46 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.
    Personal Author:
    Heimer, R
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):67-74
    Description:
    This chapter attempts to describe the factors influencing the transmission of syringe-born viruses, to review the effects of syringe exchange programs (SEPs) in terms of these factors, and to explore the gamut of health-promoting activities of SEPs.|...
    File Type:
    Filetype[PDF - 1.57 MB]
  2. The Public health impact of needle exchange programs in the United States and abroad; summary, conclusions, and recommendations
    Corporate Authors:
    University of California, Berkeley, School of Public Health.. University of California, San Francisco, Institute for Health Policy Studies.. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    1993
    Description:
    Prepared for the Centers for Disease Control and Prevention. Funded through a cooperative agreement with the Association of Schools of Public Health (ASPH Agreement No. M1589).The current evaluation was funded through a cooperative agreement between ...
    File Type:
    Filetype[PDF - 132.79 KB]
  3. The role of needle exchange programs in HIV prevention.
    Personal Author:
    Vlahov, D; Junge, B;
    Published Date:
    Jun 1998
    Source:
    Public Health Rep. 113(Suppl 1):75-80
    Description:
    Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States, IDUs account for nearly one-third of the cases of acquired immunodeficiency syndrome (AIDS), eithe...
    File Type:
    Filetype[PDF - 1.90 MB]
  4. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal
    Corporate Authors:
    American Pharmaceutical Association. Centers for Disease Control and Prevention (U.S.).
    Published Date:
    November/December 2002
    Series:
    Journal of the American Pharmaceutical Association ; v. 42, no. 6, Suppl. 2
    Description:
    "This supplement to the November–December 2002 issue of JAPhA highlights pharmacy and public health cooperation to increase pharmacy syringe sales to injection drug users and to promote safe community syringe disposal.""Publication of this suppleme...
    File Type:
    Filetype[PDF - 1.06 MB]
  5. Guidance on prevention of viral hepatitis B and C among people who inject drugs
    Corporate Authors:
    World Health Organization, Department of HIV/AIDS.. Centers for Disease Control and Prevention (U.S.). United States, President's Emergency Plan for AIDS Relief.. World Health Organization.
    Published Date:
    July 2012
    Description:
    This Guidance on prevention of viral hepatitis B and C among people who inject drugs is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization. These recomm...
    File Type:
    Filetype[PDF - 1.68 MB]